Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Sleep Disturbance in Surgical Abortion
NCT06388824Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- May 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in sleep disorder comparing Placebo Group with Esketamine Group (2 arms). Primary endpoint: The incidence of sleep disturbance on the first night after surgery at 1 day. Started May 2024; status: completed.
02
Drugs
esketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT06388824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06388824.